Short answer
GE HealthCare (GEHC) filed its Q3 2026 10-Q quarterly report on Oct 28, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $5.5B (up 7.2% year over year) with net income of $614M.
Q3 2026 key financials · XBRL
- Revenue
- $5.5B
- +7.2% YoY · +4.2% QoQ
- Net income
- $614M
- +37.7% YoY · +9.4% QoQ
- Operating margin
- 14.6%
- Gross margin
- 40.3%
- EPS (diluted)
- $1.36
- +40.2% YoY · +10.6% QoQ
Source: XBRL data from the GE HealthCare (GEHC) Q3 2026 10-Q on SEC EDGAR. USD.
GE HealthCare Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $5,513M, up 7.2% YoY from $5,143M, organic growth 6.2%
- Operating margin 14.6% vs 12.7% YoY, net margin 11.1% vs 8.7%
- Best segment PDx: revenue $846M, up 13.0%; worst PCS: nine-month revenue $2,171M, down 4.0%
- Operating cash flow $1,365M through nine months, up from $937M; $2,293M acquisition spending
- Tariffs reduced Q3 operating income by $53M; management expects continued material impacts if tariffs persist at current levels
Risk Factors
- No material changes to risk factors disclosed in the December 31, 2025 Form 10-K
- Significant carried-forward risks remain unchanged from the latest annual filing
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other GE HealthCare quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.